Is Plasma Fibrinogen Useful in Evaluating Ischemic Stroke Patients? Why, How, and When

被引：27
|
作者：
Di Napoli, Mario [1 ]
Singh, Puneetpal [2 ]
机构：
[1] San Camillo de Lellis Gen Hosp, Neurol Sect, Rieti, Italy
[2] Punjabi Univ, Dept Human Biol, Mol Genet Lab, Patiala, Punjab, India
来源：
STROKE | 2009年 / 40卷 / 05期
关键词：
fibrinogen; risk factor; cerebrovascular disease; inflammation; outcome; prognosis; C-REACTIVE PROTEIN; RANDOMIZED CONTROLLED-TRIAL; BETA-FIBRINOGEN; HEMOSTATIC MARKERS; CEREBRAL INFARCTION; CARDIOVASCULAR EVENTS; INTRAVENOUS ANCROD; GENE POLYMORPHISM; TERM RISK; ATHEROSCLEROSIS;
D O I：
10.1161/STROKEAHA.108.537084
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：1549 / 1552
页数：4
相关论文
共 50 条
  • [41] Stroke and bleeding risk assessment in atrial fibrillation: when, how, and why?
    Lip, Gregory Y. H.
    EUROPEAN HEART JOURNAL, 2013, 34 (14) : 1041 - 1049
  • [42] Fibrinogen as predictor of ischemic stroke in patients with non-valvular atrial fibrillation
    Di Lecce, VN
    Loffredo, L
    Fimognari, FL
    Cangemi, R
    Violi, F
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (11) : 2453 - 2455
  • [43] β-fibrinogen gene-455A/G polymorphism and plasma fibrinogen level in Chinese stroke patients
    Liu, Y
    Pan, JQ
    Wang, SJ
    Li, XR
    Huang, YN
    CHINESE MEDICAL JOURNAL, 2002, 115 (02) : 214 - 216
  • [44] Fibrinogen concentration in the evaluation of safety and efficiency of thrombolytic therapy in patients with ischemic stroke
    Lyang, O. V.
    Kochetov, A. G.
    Shamalov, N. A.
    Anisimov, K. V.
    Ramazanov, G. R.
    Arkhipkin, A. A.
    Novozhenova, Yu. V.
    Kustova, M. A.
    Podshivalov, D. S.
    Egorov, V. O.
    Skvortsova, V. I.
    TERAPEVTICHESKII ARKHIV, 2012, 84 (10) : 42 - 47
  • [45] Strongly increased levels of fibrinogen elastase degradation products in patients with ischemic stroke
    de Lau, Lonneke M. L.
    Cheung, Elim Y. L.
    Kluft, Cornelis
    Leebeek, Frank W. G.
    Meijer, Piet
    Laterveer, Ria
    Dippel, Diederik W. J.
    de Maat, Moniek P. M.
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 143 (05) : 734 - 737
  • [46] Study for β-fibrinogen G/A-455 polymorphism in Korean ischemic stroke patients
    Cho, HJ
    Han-Jin, C
    Hoon-Pyo, H
    Myung-Chun, K
    Young-Gwan, K
    ANNALS OF EMERGENCY MEDICINE, 2004, 44 (04) : S52 - S53
  • [47] The prognostic significance of fibrinogen concentration in patients with ischemic stroke without thrombolytic treatment
    Kochetov, A. G.
    Karpova, O. V.
    Arhipkin, A. A.
    Novozhenova, U. V.
    Shamalov, N. A.
    Ramazanov, G. R.
    Lukianov, A. L.
    Skvortsova, V. I.
    ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2010, 110 (12) : 46 - 51
  • [48] β-fibrinogen gene-455 G/A polymorphism in Korean ischemic stroke patients
    Lee, Seung-Han
    Kim, Myeong-Kyu
    Park, Man-Seok
    Choi, Seong-Nen
    Kim, Joon-Tae
    Kim, Byeong-Chae
    Cho, Ki-Hyun
    JOURNAL OF CLINICAL NEUROLOGY, 2008, 4 (01): : 17 - 22
  • [49] Bariatric Surgery for ESKD Patients: Why, When, and How?
    Erickson, Kevin F.
    Navaneethan, Sankar D.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2019, 14 (08): : 1125 - 1127
  • [50] Thromboprophylaxis in critically ill patients: When? Why? How?
    Prat, G.
    Delluc, A.
    Renault, A.
    Lacut, K.
    REANIMATION, 2011, 20 (02): : 118 - 123
12345